Neuropace Inc
NASDAQ:NPCE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Guangzhou Frontop Digital Creative Technology Co Ltd
SZSE:301313
|
CN |
|
Zhejiang Tiantie Industry Co Ltd
SZSE:300587
|
CN |
|
C
|
CTX Virtual Technologies Inc
OTC:CTXV
|
US |
|
K
|
Kosy JSC
VN:KOS
|
VN |
|
C
|
Chijet Motor Co Inc
NASDAQ:CJET
|
CN |
|
A
|
Aidigong Maternal & Child Health Ltd
OTC:GPRHF
|
HK |
|
Identillect Technologies Corp
XTSX:ID
|
CA |
|
BHG Retail REIT
SGX:BMGU
|
SG |
|
C
|
Changchun Zhiyuan New Energy Equipment Co Ltd
SZSE:300985
|
CN |
Neuropace Inc
No
Economic Moat
Neuropace Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Neuropace Inc
Competitive Advantages
Wide Economic Moat Companies
| Company | Last Price | Price Change | Market Cap | Economic Moat | ||
|---|---|---|---|---|---|---|
|
|
|
NVIDIA Corp
NVDA
|
$182.08 |
+0.8%
|
$4.4T | Wide |
|
|
|
Apple Inc
AAPL
|
$258.9 |
+2.1%
|
$3.8T | Wide |
|
|
|
Alphabet Inc
GOOGL
|
$317.32 |
-0.2%
|
$3.8T | Wide |
|
|
|
Microsoft Corp
MSFT
|
$374.33 |
+1%
|
$2.8T | Wide |
|
|
|
Amazon.com Inc
AMZN
|
$221.25 |
+1.6%
|
$2.4T | Wide |
|
|
|
Taiwan Semiconductor Manufacturing Co Ltd
2330
|
NT$1 950 |
+2.6%
|
$1.6T | Wide |
|
|
|
Meta Platforms Inc
META
|
$612.42 |
+0.1%
|
$1.5T | Wide |
|
|
|
Broadcom Inc
AVGO
|
$350.63 |
-2%
|
$1.7T | Wide |
|
|
|
Walmart Inc
WMT
|
$127.26 |
+0.6%
|
$1T | Wide |
|
|
|
Eli Lilly and Co
LLY
|
$953.3 |
-1.3%
|
$901.2B | Wide |
| Company | Last Price | Price Change | Market Cap | Economic Moat | ||
|---|---|---|---|---|---|---|
|
|
|
AstraZeneca PLC
AZN
|
GBX15 216 |
-0.1%
|
$318.4B | Wide |
|
|
|
Kweichow Moutai Co Ltd
600519
|
¥1 465.02 |
+1.7%
|
$266.5B | Wide |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr241.65 |
-1.9%
|
$169.2B | Wide |
|
|
|
Zhongji Innolight Co Ltd
300308
|
¥688.14 |
+2.5%
|
$111.1B | Wide |
|
|
|
GE Healthcare Technologies Inc
GEHC
|
$73.75 |
+0%
|
$33.6B | Wide |
|
|
|
Bajaj Auto Ltd
BAJAJ-AUTO
|
₹9 396 |
+2.5%
|
$28.9B | Wide |
|
|
|
Hindustan Aeronautics Ltd
HAL
|
₹3 911.1001 |
+0.8%
|
$28.8B | Wide |
|
|
|
Adani Green Energy Ltd
ADANIGREEN
|
₹1 024.45 |
-2%
|
$18.6B | Wide |
|
|
|
ABB India Ltd
ABB
|
₹6 559.5 |
+2%
|
$15.3B | Wide |
|
|
|
Trent Ltd
TRENT
|
₹3 904.3 |
-0.2%
|
$15.3B | Wide |
Neuropace Inc
Glance View
NeuroPace, Inc. develops, manufactures and markets implantable devices for treating epilepsy and neurological disorders. The company is headquartered in Mountain View, California. The company went IPO on 2021-04-22. The firm is focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company’s novel and differentiated RNS System is the brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. The Company’s RNS System is a platform that delivers care for patients suffering from drug-resistant epilepsy and offers a personalized solution and outcomes to the patients suffering from other brain disorders. RNS System is a device that records brain activity data and clinicians to monitor patients. RNS System monitors the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is engaged in treating other brain disorders including depression, impulse control disorders, memory disorders, and post-traumatic stress.
Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.
The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.
Note: This research does not account for survivorship bias. Past performance is not indicative of future results.
Economic Moat
